Filing Details
- Accession Number:
- 0001209191-23-020244
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-21 16:21:13
- Reporting Period:
- 2023-03-17
- Accepted Time:
- 2023-03-21 16:21:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1223348 | Jr F Charles Wagner | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-17 | 360 | $294.52 | 53,019 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-17 | 784 | $295.43 | 52,235 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-17 | 240 | $296.30 | 51,995 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-17 | 360 | $298.09 | 51,635 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-17 | 240 | $299.58 | 51,395 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-17 | 16 | $301.13 | 51,379 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was adopted on 08/08/2022.
- Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $294.52 (range $293.98 to $294.81).
- Open market sales reported on this line occurred at a weighted average price of $295.43 (range $295.09 to $295.97).
- Open market sales reported on this line occurred at a weighted average price of $296.30 (range $296.14 to $296.45).
- Open market sales reported on this line occurred at a weighted average price of $298.09 (range $297.65 to $298.48).
- Open market sales reported on this line occurred at a weighted average price of $299.58 (range $299.09 to $300.06).
Billionaire Hedge Funds
